Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
about
Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipientCD46-induced immunomodulatory CD4+ T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cellsThe kidney in thrombotic thrombocytopenic purpura.Complement factor H: using atomic resolution structure to illuminate disease mechanisms.Atypical hemolytic uremic syndrome in the Tunisian population.Assesment, treatment and prevention of atypical hemolytic uremic syndrome.Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.Complement regulators in human disease: lessons from modern genetics.Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic SyndromeAtypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.Efficacy of rituximab and plasmapharesis in an adult patient with antifactor H autoantibody-associated hemolytic uremic syndrome: A case report and literature reviewAbsence of thrombocytopaenia and/or microangiopathic haemolytic anaemia does not reliably exclude recurrence of atypical haemolytic uraemic syndrome after kidney transplantation.Atypical Hemolytic Uremic Syndrome: A Brief Review.Complement, age-related macular degeneration and a vision of the futureAge-related macular degeneration: genetic and clinical findings.Maintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literaturePregnancy-induced atypical haemolytic uremic syndrome: A new era with eculizumab.Atypical hemolytic uremic syndromeManagement of hemolytic uremic syndromeHemolytic uremic syndromeAn adult case of atypical hemolytic uremic syndrome presented with posterior reversible encephalopathy syndrome: Successful response to late-onset eculizumab treatmentBe on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases
P2860
Q24601710-D82ADE21-CCB8-4E1B-B850-2FC4D6A96972Q30484954-4B78FA55-EBE4-4CD6-AC39-50A9003CCBE0Q33378755-0360A289-FDF0-4344-8EC7-CD720DFCF78EQ33382097-7B2550CC-A5E1-410D-BB0B-A3A947E39BA8Q33389773-875D4577-BDB5-48C5-B982-B49C52423E1FQ33405916-D48F8D79-1CA3-4889-B8F0-1A5E926E3617Q33406025-79C7776B-3E0C-46C2-9583-3A97EB5837FDQ33419261-948852A0-0271-4473-95CC-ECDCA67D6C77Q33421800-A775FEEF-7241-42C9-98B5-D8E950090510Q33424946-7E7E585A-07CE-4312-946C-9FACAD46BBCBQ33435662-6E838D9B-807E-4A81-B6D5-E6B113CE5FEEQ33439125-0A64D195-A83D-4AA9-944B-83E7381C5EEBQ33442794-C3C27E83-CD6A-4DDE-A9BA-F3F64FFF9357Q35509833-FA96D09A-96B2-45C5-99B5-99B450F21A2CQ37822792-37139CAB-D0B2-4858-8FF4-C8D706E496B2Q38927860-4D3DC345-D209-45A1-8EA2-BE094E49FABCQ52595152-B9612C97-9647-4A55-BEE3-A21AD7BAD5CAQ56591965-571C7736-510A-48F0-B65B-3D7F706D78CAQ57161996-102BBF92-4217-4D08-AC8B-0AD196B459ADQ57701679-284C9857-FFE8-45CE-A143-3F7FF77B4772Q57821657-C084DD5E-1772-411C-BB59-6A42ADC6DDDFQ58795472-6181D03F-42B9-435B-8C61-A31272345481
P2860
Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Screening for complement syste ...... cal hemolytic uremic syndrome.
@ast
Screening for complement syste ...... cal hemolytic uremic syndrome.
@en
type
label
Screening for complement syste ...... cal hemolytic uremic syndrome.
@ast
Screening for complement syste ...... cal hemolytic uremic syndrome.
@en
prefLabel
Screening for complement syste ...... cal hemolytic uremic syndrome.
@ast
Screening for complement syste ...... cal hemolytic uremic syndrome.
@en
P2093
P50
P356
P1476
Screening for complement syste ...... cal hemolytic uremic syndrome.
@en
P2093
Anna Richards
John P Atkinson
Marina Noris
Timothy Goodship
Veronique Fremeaux-Bacchi
P304
P356
10.2215/CJN.03270906
P577
2007-02-14T00:00:00Z